Inst Diagnosti Return On Equity vs. Revenue

INDISA Stock  CLP 1,588  2.60  0.16%   
Considering the key profitability indicators obtained from Inst Diagnosti's historical financial statements, Inst Diagnosti may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Inst Diagnosti's ability to earn profits and add value for shareholders.
For Inst Diagnosti profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Inst Diagnosti to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Inst Diagnosti utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Inst Diagnosti's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Inst Diagnosti over time as well as its relative position and ranking within its peers.
  
Check out Risk vs Return Analysis.
Please note, there is a significant difference between Inst Diagnosti's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inst Diagnosti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inst Diagnosti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Inst Diagnosti Revenue vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Inst Diagnosti's current stock value. Our valuation model uses many indicators to compare Inst Diagnosti value to that of its competitors to determine the firm's financial worth.
Inst Diagnosti is rated below average in return on equity category among its peers. It also is rated below average in revenue category among its peers totaling about  969,871,862,140  of Revenue per Return On Equity. Comparative valuation analysis is a catch-all model that can be used if you cannot value Inst Diagnosti by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Inst Diagnosti's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Inst Revenue vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Inst Diagnosti

Return On Equity

 = 

Net Income

Total Equity

 = 
0.19
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Inst Diagnosti

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
188.54 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Inst Revenue vs Competition

Inst Diagnosti is rated below average in revenue category among its peers. Market size based on revenue of Medical Care industry is currently estimated at about 6.53 Trillion. Inst Diagnosti holds roughly 188.54 Billion in revenue claiming about 2.89% of all equities under Medical Care industry.

Inst Diagnosti Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Inst Diagnosti, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Inst Diagnosti will eventually generate negative long term returns. The profitability progress is the general direction of Inst Diagnosti's change in net profit over the period of time. It can combine multiple indicators of Inst Diagnosti, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Instituto de Diagnstico S.A. provides healthcare services in various medical specialties and sub-specialties in Chile. The company was founded in 1961 and is based in Providencia, Chile. INST DIAGNOSTICO is traded on Commodity Exchange in Exotistan.

Inst Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Inst Diagnosti. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Inst Diagnosti position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Inst Diagnosti's important profitability drivers and their relationship over time.

Use Inst Diagnosti in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Inst Diagnosti position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inst Diagnosti will appreciate offsetting losses from the drop in the long position's value.

Inst Diagnosti Pair Trading

Inst Diagnosti Pair Trading Analysis

The ability to find closely correlated positions to Inst Diagnosti could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Inst Diagnosti when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Inst Diagnosti - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Inst Diagnosti to buy it.
The correlation of Inst Diagnosti is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Inst Diagnosti moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Inst Diagnosti moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Inst Diagnosti can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Inst Diagnosti position

In addition to having Inst Diagnosti in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Beers Thematic Idea Now

Beers
Beers Theme
Companies involved in production and distribution of domestic and international beer. The Beers theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Beers Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Inst Stock

To fully project Inst Diagnosti's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Inst Diagnosti at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Inst Diagnosti's income statement, its balance sheet, and the statement of cash flows.
Potential Inst Diagnosti investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Inst Diagnosti investors may work on each financial statement separately, they are all related. The changes in Inst Diagnosti's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Inst Diagnosti's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.